Inhibitors Against Glycosidases as Medicines

Author(s): Tetsuya Kajimoto, Manabu Node.

Journal Name: Current Topics in Medicinal Chemistry

Volume 9 , Issue 1 , 2009

Become EABM
Become Reviewer


Glycosidases mediate the digestion of oligosaccharides in the small intestine as well as the processing of cell surface oligosaccharides, which play important roles in cell to cell recognition during infections, metastasis, and immune responses. Thus, agents that control the activities of glycosidases could have therapeutic effects against many carbohydrate-related diseases. In fact, many fruitful efforts have been made to design and synthesize glycosidase inhibitors as clinically practical medicines. This review summarizes the current stage of development of such inhibitors to treat diabetes, influenza, virus infection of HIV, tumor metastasis, and glycosyl sphingo lipid (GSL) storage diseases.

Keywords: Glycosidases, oligosaccharides, carbohydrate-related diseases, inhibitors, virus infection of HIV, tumor metastasis, glycosyl sphingo lipid (GSL)

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [13 - 33]
Pages: 21
DOI: 10.2174/156802609787354333

Article Metrics

PDF: 29